{"id":"https://genegraph.clinicalgenome.org/r/f059d00b-0868-480d-a1d6-2a29425723e1v1.1","type":"EvidenceStrengthAssertion","dc:description":["The *KCNC3* gene, located on chromosome 19 at 19q13.33, encodes the potassium voltage-gated channel subfamily C member 3 (KCNC3), which plays an important role in regulation of the action potential and the rapid repolarization of fast-firing brain neurons. \n*KCNC3* was first reported in relation to autosomal dominant spinocerebellar ataxia 13 in 2006 (Waters et al., PMID: 16501573). Spinocerebellar ataxia 13 is characterized by slowly progressive gait and limb ataxia and dysarthria, with other variable features including intellectual impairment, oculomotor disturbances, and pyramidal signs. \n\nTwelve missense variants that have been reported in 18 probands from 8 publications (PMIDs: 16501573, 19953606, 25981959, 25756792, ​​28444220, 29482223, 31907387, 33446253) are included in this curation. Variants in this gene segregated with disease in at least 17 additional family members (PMID: 16501573). Of note, an autosomal recessive  case with a homozygous missense variant has been reported in one proband (PMID: 38374194).This gene-disease relationship is also supported by experimental evidence such as a cell culture model, two zebrafish models, and rescue in a knockout mouse (PMIDs: 24218544, 20712895, 21543613, 18448641). \n\nIn summary, there is definitive evidence to support the relationship between *KCNC3* and autosomal dominant spinocerebellar ataxia 13. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Cerebral Palsy Gene Curation Expert Panel on the meeting date November 7th, 2024 (SOP Version 11).\n","The *KCNC3* gene, located on chromosome 19 at 19q13.33, encodes the potassium voltage-gated channel subfamily C member 3 (KCNC3), which plays an important role in regulation of the action potential and the rapid repolarization of fast-firing brain neurons. *KCNC3* was first reported in relation to autosomal dominant spinocerebellar ataxia 13 in 2006 (Waters et al., PMID: 16501573). Spinocerebellar ataxia 13 is characterized by slowly progressive gait and limb ataxia and dysarthria, with other variable features including intellectual impairment, oculomotor disturbances, and pyramidal signs. \n\nTwelve missense variants that have been reported in 18 probands from 8 publications (PMIDs: 16501573, 19953606, 25981959, 25756792, ​​28444220, 29482223, 31907387, 33446253) are included in this curation. Variants in this gene segregated with disease in at least 17 additional family members (PMID: 16501573). Of note, an autosomal recessive  case with a homozygous missense variant has been reported in one proband (PMID: 38374194).This gene-disease relationship is also supported by experimental evidence such as a cell culture model, two zebrafish models, and rescue in a knockout mouse (PMIDs: 24218544, 20712895, 21543613, 18448641). \n\nIn summary, there is definitive evidence to support the relationship between *KCNC3* and autosomal dominant spinocerebellar ataxia 13. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Cerebral Palsy Gene Curation Expert Panel on the meeting date November 7th, 2024 (SOP Version 11).\n"],"dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/f059d00b-0868-480d-a1d6-2a29425723e1","GCISnapshot":"https://genegraph.clinicalgenome.org/r/18613a4a-5124-499a-b224-1c4aae4b1c55","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/18613a4a-5124-499a-b224-1c4aae4b1c55_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10113","date":["2024-11-07T17:00:00.000Z","2024-11-07T05:00:00.000Z"],"role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/18613a4a-5124-499a-b224-1c4aae4b1c55_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10113","date":"2025-02-05T15:24:37.480Z","role":"Publisher"}],"curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/18613a4a-5124-499a-b224-1c4aae4b1c55_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/18613a4a-5124-499a-b224-1c4aae4b1c55_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ddbfed00-1321-4410-a8a7-e2d83a94ed9b","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4fb2a767-813b-492c-8a64-4b964378ca17","type":"Finding","dc:description":"Kv3.3-deficient mice had no obvious learning or memory deficit but displayed muscle twitches and motor dysfunction, suggested by increased lateral deviation while ambulating and slips on a narrow beam. Kv3.3-deficient Purkinje cells also revealed broadened simple spikes and fewer spikelets in complex spikes. Targeted reexpression of Kv3.3 channels rescued both the spike parameters and motor coordination","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18448641","rdfs:label":"Hurlock rescue in targeted KO mouse","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/1be92518-4340-4798-bbb8-acdc47d438b2","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b7aa4ad2-2b79-4258-96c0-ff0aa172c891","type":"Finding","dc:description":"As with human Kv3.3, the variant causes a dominant‐negative effect by suppressing outward currents, broadening action potentials and elevating basal intracellular calcium concentration in Purkinje cells. It also produced more profound cell biology changes. Purkinje cells expressing the mutant Kv3.3 became smaller in size than control cells and their dendrites became shorter and less elaborate. The density of cells expressing the mutant channels declined more rapidly than that of control Purkinje cells, suggesting that the variant increases the rate of cell death\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24218544","rdfs:label":"Irie cell model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityCellCultureModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/1079d8a9-b8fb-40c8-b5ad-df978329423b","type":"EvidenceLine","dc:description":"Downgraded by half of default points since this is a Zebrafish model ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f00ba0c3-7854-4669-92b3-51dd6dd874ab","type":"Finding","dc:description":"SCA13 variants have similar effects on human and zebrafish Kv3.3 channels. Similarly to R420H, the corresponding mutation R335H was not functional when expressed alone but exerted a dominant negative effect on the activity of the zebrafish wild type subunit. F363L corresponds to the human mutation F448L, which generated functional channels in oocytes. Voltage dependence of pore opening was shifted in the hyperpolarized direction by -7.6 mV compared to wild type Kv3.3 and dramatically slowed channel deactivation.\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20712895","rdfs:label":"Mock Zebrafish","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/4a3dc619-6be9-459c-921e-d47b5da5dd12","type":"EvidenceLine","dc:description":"Downgraded by half of the default since this is a Zebrafish model","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a48d010e-f876-412b-86e5-21c5c4aca2be","type":"Finding","dc:description":"Zebrafish injected with RNA encoding R420H showed reduced neuronal excitability. The variant significantly reduced the amplitude of outward currents in CaP neurons and the average action potential firing rate compared with EGFP-injected or uninjected controls. Action potentials in R420H-expressing neurons tended to be smaller in amplitude and longer in duration. The mutants also showed significantly decreased number of spikes per burst in CaP motor neurons during fictive swimming. Locomotor deficits observed in the mutant zebrafish include impaired execution of the startle response to tactile stimuli, reducing the amplitude and increasing the variability of muscle contractions. These changes in motor behavior are similar gait changes in human ataxia. Mutants developed normally otherwise, with no obvious delay and no gross locomotor deficits.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21543613","rdfs:label":"Issa Zebrafish","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/18613a4a-5124-499a-b224-1c4aae4b1c55_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/74bbfc63-8580-4c9a-8f86-1483ee7d0dd9","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/74bbfc63-8580-4c9a-8f86-1483ee7d0dd9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25981959","allele":{"id":"https://genegraph.clinicalgenome.org/r/16654125-77db-402f-9ca9-54b1c14ac997","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004977.3(KCNC3):c.1283C>T (p.Thr428Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10584651"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/74bbfc63-8580-4c9a-8f86-1483ee7d0dd9_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"In vitro electrophysiologic studies showed that the mutant protein resulted in a nonfunctional channel and acted in a dominant-negative manner when coexpressed with wildtype KCNC3. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/ed35eeb9-d61c-4deb-bd7a-2b2a8f87bb95","type":"EvidenceLine","dc:description":"This variant was not scored due to a high gnomAD frequency.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ed35eeb9-d61c-4deb-bd7a-2b2a8f87bb95_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31692161","allele":{"id":"https://genegraph.clinicalgenome.org/r/1cd495cf-f505-4db3-bff9-b72faad4a256","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004977.3(KCNC3):c.691G>A (p.Gly231Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA309575868"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/18613a4a-5124-499a-b224-1c4aae4b1c55_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c50328a8-7fdf-4c90-800a-8ae60271bbf6_proband_segregation","type":"FamilyCosegregation","dc:description":"A genome-wide linkage scan was performed","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16501573","rdfs:label":"Waters family 2","estimatedLodScore":2.11,"family":{"id":"https://genegraph.clinicalgenome.org/r/c50328a8-7fdf-4c90-800a-8ae60271bbf6","type":"Family","rdfs:label":"Waters family 2","member":{"id":"https://genegraph.clinicalgenome.org/r/89d1f0e9-4e9d-43f5-99fb-35e62b2d48a8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16501573","rdfs:label":"Family 2 proband IV-1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":5,"allele":{"id":"https://genegraph.clinicalgenome.org/r/dbf9186f-e96d-430c-8c1b-c0708f1aa483","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004977.3(KCNC3):c.1344C>A (p.Phe448Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA256862"}},"firstTestingMethod":"Linkage analysis","phenotypeFreeText":"Cerebral MRI: moderate cerebellar and pontine atrophy","phenotypes":["obo:HP_0001270","obo:HP_0007240","obo:HP_0001260","obo:HP_0002342","obo:HP_0001347","obo:HP_0011152","obo:HP_0002073"],"secondTestingMethod":"PCR","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/38ea9bd8-7626-4106-92fb-a2d2f72fb2f5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16501573","allele":{"id":"https://genegraph.clinicalgenome.org/r/dbf9186f-e96d-430c-8c1b-c0708f1aa483"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Cerebral MRI: moderate cerebellar and pontine atrophy","phenotypePositiveAllelePositive":8,"phenotypes":["obo:HP_0002342","obo:HP_0007240","obo:HP_0001347","obo:HP_0001270","obo:HP_0002073","obo:HP_0001260","obo:HP_0011152"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/89d1f0e9-4e9d-43f5-99fb-35e62b2d48a8"},"publishedLodScore":3.8,"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/86ba0a28-f01f-498f-940e-0f0fc0198858_proband_segregation","type":"FamilyCosegregation","dc:description":"A genome-wide linkage scan was performed","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16501573","rdfs:label":"Waters family 1","estimatedLodScore":3.01,"family":{"id":"https://genegraph.clinicalgenome.org/r/86ba0a28-f01f-498f-940e-0f0fc0198858","type":"Family","rdfs:label":"Waters family 1","member":{"id":"https://genegraph.clinicalgenome.org/r/604636ef-3829-482d-a119-2b8298f6ddd0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16501573","rdfs:label":"Family 1 Proband II-1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":65,"allele":{"id":"https://genegraph.clinicalgenome.org/r/f33d3574-d472-4ac5-a24c-d2327b68bb2c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004977.3(KCNC3):c.1259G>A (p.Arg420His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA256861"}},"firstTestingMethod":"Linkage analysis","phenotypes":["obo:HP_0003581","obo:HP_0001272","obo:HP_0001251"],"secondTestingMethod":"PCR","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/6ef45d79-c004-4cb1-b5fa-6ca8eb440825_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16501573","allele":{"id":"https://genegraph.clinicalgenome.org/r/f33d3574-d472-4ac5-a24c-d2327b68bb2c"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":11,"phenotypes":["obo:HP_0001272","obo:HP_0001251","obo:HP_0003581"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/604636ef-3829-482d-a119-2b8298f6ddd0"},"publishedLodScore":3.83,"sequencingMethod":{"id":"cg:AllGenesSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/b327b87a-2006-49ea-869f-f847cf9e5e51","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b327b87a-2006-49ea-869f-f847cf9e5e51_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19953606","allele":{"id":"https://genegraph.clinicalgenome.org/r/f33d3574-d472-4ac5-a24c-d2327b68bb2c"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/b327b87a-2006-49ea-869f-f847cf9e5e51_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"No detectable channel activity when expressed alone, and strong dominant negative effects when coexpressed with wild-type\n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/885f427c-264f-4479-932e-060ff0658c12","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/885f427c-264f-4479-932e-060ff0658c12_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25756792","allele":{"id":"https://genegraph.clinicalgenome.org/r/6cd67c20-392f-4e08-a85e-52de5a39e9ba","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004977.3(KCNC3):c.1268G>A (p.Arg423His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA204646"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/885f427c-264f-4479-932e-060ff0658c12_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Whole-cell patch-clamp experiments in CHO-K1 cells expressing the variant confirmed significant loss of Kv3.3 channel activity ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/5393e5de-d42d-48dc-afb5-88ad074699ae","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5393e5de-d42d-48dc-afb5-88ad074699ae_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28444220","allele":{"id":"https://genegraph.clinicalgenome.org/r/8f874601-621d-4127-96ae-bd120a86df5d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004977.3(KCNC3):c.1420G>A (p.Ala474Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA406951249"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/90758a03-0de0-42de-bbf3-e410ceefaebe","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/90758a03-0de0-42de-bbf3-e410ceefaebe_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25756792","allele":{"id":"https://genegraph.clinicalgenome.org/r/f33d3574-d472-4ac5-a24c-d2327b68bb2c"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/90758a03-0de0-42de-bbf3-e410ceefaebe_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Whole-cell patch-clamp experiments in CHO-K1 cells expressing variant confirmed significant loss of Kv3.3 channel activity due to the variant","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ae2f99fc-7b26-4a29-b176-72c0394f64ed","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ae2f99fc-7b26-4a29-b176-72c0394f64ed_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29482223","allele":{"id":"https://genegraph.clinicalgenome.org/r/26807318-08f6-4724-9587-40daa363aef3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004977.3(KCNC3):c.1696C>T (p.Pro566Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA9594190"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/d14b1b92-08ca-4aa1-b1e3-af00143a9fbc","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d14b1b92-08ca-4aa1-b1e3-af00143a9fbc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25756792","allele":{"id":"https://genegraph.clinicalgenome.org/r/99897529-d8ec-4038-9715-fe5106e085f3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004977.3(KCNC3):c.385G>A (p.Asp129Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA406955840"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/d14b1b92-08ca-4aa1-b1e3-af00143a9fbc_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Voltage dependence of activation shifted to more hyperpolarised voltage by -6 mV","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/4484a971-4a23-4ac7-9ec3-b8cbcaf440b2","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4484a971-4a23-4ac7-9ec3-b8cbcaf440b2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29482223","allele":{"id":"https://genegraph.clinicalgenome.org/r/b1cfd7b8-7186-4013-99e1-ca6577fe130a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004977.3(KCNC3):c.2096G>A (p.Gly699Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA406968731"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/bce97b82-d0fd-4984-ab1f-cb76c31ecf39","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bce97b82-d0fd-4984-ab1f-cb76c31ecf39_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19953606","allele":{"id":"https://genegraph.clinicalgenome.org/r/f33d3574-d472-4ac5-a24c-d2327b68bb2c"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/bce97b82-d0fd-4984-ab1f-cb76c31ecf39_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"No detectable channel activity when expressed alone, and strong dominant negative effects when coexpressed with wild-type\nNo detectable channel activity when expressed alone, and strong dominant negative effects when coexpressed with wild-type","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/6ebe74b4-21ad-4c10-aa24-96f8c536407b","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6ebe74b4-21ad-4c10-aa24-96f8c536407b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31907387","allele":{"id":"https://genegraph.clinicalgenome.org/r/b964a75d-4b2b-407c-8d63-066111cd22f7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004977.3(KCNC3):c.1973G>A (p.Arg658Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA406949462"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/8af6ff8c-9970-4628-a064-7832091f6452","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8af6ff8c-9970-4628-a064-7832091f6452_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19953606","allele":{"id":"https://genegraph.clinicalgenome.org/r/6cd67c20-392f-4e08-a85e-52de5a39e9ba"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/8af6ff8c-9970-4628-a064-7832091f6452_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The mutant when co-expressed with the wild-type subunit exerted a severe dominant negative loss-of-function phenotype, reducing overall channel activity to below 50% of that seen with the wild-type channel alone ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/0086b19a-9b19-4701-b09d-c6ea38bd5ff5","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0086b19a-9b19-4701-b09d-c6ea38bd5ff5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28444220","allele":{"id":"https://genegraph.clinicalgenome.org/r/6cd67c20-392f-4e08-a85e-52de5a39e9ba"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/0086b19a-9b19-4701-b09d-c6ea38bd5ff5_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The mutant when co-expressed with the wild-type subunit exerted a severe dominant negative loss-of-function phenotype, reducing overall channel activity to below 50% of that seen with the wild-type channel alone (PMID: 19953606)","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/38ea9bd8-7626-4106-92fb-a2d2f72fb2f5","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/38ea9bd8-7626-4106-92fb-a2d2f72fb2f5_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/38ea9bd8-7626-4106-92fb-a2d2f72fb2f5_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The variant shifts the activation curve in negative direction and causes approximately sevenfold slowing of channel closure.\n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e5df2e37-8555-4893-a1b5-8e0f7d538ca8","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e5df2e37-8555-4893-a1b5-8e0f7d538ca8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33446253","allele":{"id":"https://genegraph.clinicalgenome.org/r/e9c84b6e-573b-48fc-8ec1-a978bfa1b2d7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004977.3(KCNC3):c.2105G>T (p.Ser702Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA9594108"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/7621411e-1e54-4607-b322-1c947a22c9ec","type":"EvidenceLine","dc:description":"The variant is a likely benign variant with a high gnomAD frequency","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7621411e-1e54-4607-b322-1c947a22c9ec_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31907387","allele":{"id":"https://genegraph.clinicalgenome.org/r/95a25171-c198-4b1e-b9b3-07c44248fcdf","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004977.3(KCNC3):c.1018G>A (p.Val340Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA9594304"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/3712d02d-c05a-4e77-b959-bdcaa37c8ec2","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3712d02d-c05a-4e77-b959-bdcaa37c8ec2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19953606","allele":{"id":"https://genegraph.clinicalgenome.org/r/f33d3574-d472-4ac5-a24c-d2327b68bb2c"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/3712d02d-c05a-4e77-b959-bdcaa37c8ec2_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"No detectable channel activity when expressed alone, and strong dominant negative effects when coexpressed with wild-type","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/6ef45d79-c004-4cb1-b5fa-6ca8eb440825","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6ef45d79-c004-4cb1-b5fa-6ca8eb440825_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/6ef45d79-c004-4cb1-b5fa-6ca8eb440825_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"No channel activity was detected when expressed alone, and strong dominant negative effects was observed when coexpressed with wild-type\n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/8c277a78-b066-452f-bcdd-cb596ec75a18","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8c277a78-b066-452f-bcdd-cb596ec75a18_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19953606","allele":{"id":"https://genegraph.clinicalgenome.org/r/6cd67c20-392f-4e08-a85e-52de5a39e9ba"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/8c277a78-b066-452f-bcdd-cb596ec75a18_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The mutant when co-expressed with the wild-type subunit exerted a severe dominant negative loss-of-function phenotype, reducing overall channel activity to below 50% of that seen with the wild-type channel alone ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9b8142ee-1c95-40d2-9a0d-e772ef448542","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9b8142ee-1c95-40d2-9a0d-e772ef448542_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25756792","allele":{"id":"https://genegraph.clinicalgenome.org/r/3e46404a-7b9a-4b2f-97bc-11bc7c0d8130","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004977.3(KCNC3):c.1603G>A (p.Val535Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA406950616"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/9b8142ee-1c95-40d2-9a0d-e772ef448542_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Voltage dependence of activation shifted to more hyperpolarised voltage by -28 mV\n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/11d9d0a1-26b0-4a5b-9068-f2cfc18d6e21","type":"EvidenceLine","dc:description":"The variant is likely a benign variant with a high gnomAD frequency","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/11d9d0a1-26b0-4a5b-9068-f2cfc18d6e21_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25756792","allele":{"id":"https://genegraph.clinicalgenome.org/r/e020bd62-5b37-44cf-a752-519e264b906b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004977.3(KCNC3):c.1771A>G (p.Ser591Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA9594171"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/11d9d0a1-26b0-4a5b-9068-f2cfc18d6e21_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"significantly reduced channel activity (22%) compared with WT, shifted the V1/2 act to more depolarized voltages by +16 mV, with a slightly reduction of the slope factor","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":11}],"evidenceStrength":"Definitive","sequence":9925,"specifiedBy":"GeneValidityCriteria11","strengthScore":15,"subject":{"id":"https://genegraph.clinicalgenome.org/r/Wm4wdbUFgk4","type":"GeneValidityProposition","disease":"obo:MONDO_0011529","gene":"hgnc:6235","modeOfInheritance":"obo:HP_0000006"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_18613a4a-5124-499a-b224-1c4aae4b1c55-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}